We serve Chemical Name:4-formylpicolinonitrile CAS:131747-70-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-formylpicolinonitrile
CAS.NO:131747-70-1
Synonyms:4-Formyl-2-pyridinecarbonitrile;2-Pyridinecarbonitrile,4-formyl;4-formyl-pyridine-2-carbonitrile;2-Cyano-4-pyridinecarboxaldehyde;2-cyano-pyridine-4-carbaldehyde;4-formylpicolinonitrile;2-Cyanopyridine-4-carboxaldehyde;2-Cyanopyridine-4-aldehyde;MFCD06410676;4-formylpyridine-2-carbonitrile;2-Pyridinecarbonitrile, 4-formyl-
Molecular Formula:C7H4N2O
Molecular Weight:132.120
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:249.1±20.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.554
PSA:53.75000
Exact Mass:132.032364
LogP:0.32
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Formyl-2-pyridinecarbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyridinecarbonitrile, 4-formyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-formylpicolinonitrile Use and application,2-Cyanopyridine-4-aldehyde technical grade,usp/ep/jp grade.
Related News: We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally. 4-formylpicolinonitrile manufacturer There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 4-formylpicolinonitrile supplier We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally. 4-formylpicolinonitrile vendor The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 4-formylpicolinonitrile factory There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association.
